X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (235) 235
humans (199) 199
index medicus (150) 150
pharmacology & pharmacy (148) 148
infectious diseases (142) 142
microbial sensitivity tests (127) 127
anti-bacterial agents - pharmacology (116) 116
susceptibility (73) 73
united-states (56) 56
infections (54) 54
adult (52) 52
female (52) 52
surveillance (51) 51
antimicrobial resistance (48) 48
drug resistance, bacterial (48) 48
middle aged (47) 47
bacterial infections and mycoses (45) 45
resistance (45) 45
biochemical phenomena, metabolism, and nutrition (44) 44
male (42) 42
streptococcus pneumoniae - drug effects (42) 42
internal medicine (40) 40
escherichia-coli (39) 39
adolescent (38) 38
aged (38) 38
anti-bacterial agents - therapeutic use (37) 37
bacteria (37) 37
antibiotics (34) 34
pathogens (33) 33
canada (32) 32
drug resistance (32) 32
infectious and parasitic diseases (30) 30
enterobacteriaceae (29) 29
epidemiology (29) 29
united states (29) 29
polycyclic compounds (27) 27
prevalence (27) 27
research (27) 27
animals (25) 25
escherichia coli - drug effects (25) 25
hospitals (25) 25
streptococcus-pneumoniae (25) 25
ciprofloxacin (24) 24
pseudomonas aeruginosa - drug effects (23) 23
cephalosporins - pharmacology (22) 22
child (22) 22
gram-negative bacteria - drug effects (22) 22
immunology (22) 22
infectious disease (22) 22
fluoroquinolones (21) 21
gram-negative bacilli (21) 21
in-vitro activity (21) 21
pseudomonas aeruginosa (21) 21
urinary tract infections - microbiology (21) 21
canada - epidemiology (20) 20
drug resistance, multiple, bacterial (20) 20
infant (20) 20
escherichia coli (19) 19
escherichia coli infections - microbiology (19) 19
bacteremia (18) 18
bacteriology (18) 18
child, preschool (18) 18
medicine & public health (18) 18
mortality (18) 18
pseudomonas-aeruginosa (18) 18
staphylococcus aureus - drug effects (18) 18
anti-infective agents - pharmacology (17) 17
escherichia coli - genetics (17) 17
haemophilus influenzae - drug effects (17) 17
staphylococcus-aureus (17) 17
streptococcus pneumoniae (17) 17
aged, 80 and over (16) 16
analysis (16) 16
cross infection - microbiology (16) 16
drug resistance in microorganisms (16) 16
emergence (16) 16
gram-negative bacterial infections - microbiology (16) 16
health aspects (16) 16
identification (16) 16
infection (16) 16
klebsiella-pneumoniae (16) 16
levofloxacin (16) 16
pharmacology/toxicology (16) 16
pharmacotherapy (16) 16
strains (16) 16
urinary tract infections (16) 16
young adult (16) 16
anti-bacterial agents - pharmacokinetics (15) 15
drug resistance, microbial (15) 15
drug therapy (15) 15
gram-positive bacteria - drug effects (15) 15
haemophilus-influenzae (15) 15
infant, newborn (15) 15
molecular epidemiology (15) 15
respiratory tract infections - microbiology (15) 15
staphylococcal infections - microbiology (15) 15
streptococcus pneumoniae - isolation & purification (15) 15
treatment outcome (15) 15
women (15) 15
anti-bacterial agents - chemistry (14) 14
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Core Evidence, ISSN 1555-175X, 01/2014, Volume 9, pp. 13 - 25
Avibactam (NXL104, AVE1330A) is a semi-synthetic, non-β-lactam, β-lactamase inhibitor that is active against Ambler class A, class C, and some class D serine... 
Clinical trials | Review | Microbiology | Pharmacokinetics | β-lactamase | NXL-104 | Ceftazidime | Enzyme inhibitors | Chemotherapy | Infectious diseases | Bacterial infections | Antimicrobial agents | Urinary tract infections | Urogenital system | Urinary tract diseases | microbiology | pharmacokinetics | clinical trials | review
Journal Article
Drugs, ISSN 0012-6667, 2010, Volume 70, Issue 7, pp. 859 - 886
Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by... 
Bacterial-infections, treatment | Oritavancin, general | Research-and- development | Glycoproteins, therapeutic use | Telavancin, general | Antimicrobial-resistance | Dalbavancin, general | Skin-and-soft-tissue-infections, treatment | SOFT-TISSUE INFECTIONS | GLYCOPEPTIDE ANTIBIOTICS | GRAM-POSITIVE BACTERIA | CELL-WALL SYNTHESIS | SKIN-STRUCTURE INFECTIONS | ONCE-WEEKLY DALBAVANCIN | ENTEROCOCCUS-FAECIUM | PHARMACOLOGY & PHARMACY | TOXICOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | IN-VITRO ACTIVITY | COMPLICATED SKIN | Humans | Glycopeptides - chemistry | Teicoplanin - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Interactions | Anti-Bacterial Agents - chemistry | Gram-Positive Bacterial Infections - microbiology | Anti-Bacterial Agents - adverse effects | Molecular Structure | Glycopeptides - pharmacokinetics | Teicoplanin - pharmacokinetics | Teicoplanin - analogs & derivatives | Aminoglycosides - pharmacokinetics | Teicoplanin - chemistry | Aminoglycosides - chemistry | Treatment Outcome | Clinical Trials as Topic | Glycopeptides - adverse effects | Glycopeptides - therapeutic use | Teicoplanin - adverse effects | Animals | Anti-Bacterial Agents - pharmacokinetics | Aminoglycosides - adverse effects | Gram-Positive Bacterial Infections - drug therapy | Drug Resistance, Multiple, Bacterial - drug effects | Aminoglycosides - therapeutic use
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, p. S58
  Telavancin is a semisynthetic lipoglycopeptide derivative of vancomycin. Telavancin has a dual mechanism of antibacterial action, disrupting peptidoglycan... 
Peptides | Staphylococcus infections | Antimicrobial agents | Drug resistance
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2008, Volume 52, Issue 4, pp. 1430 - 1437
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2010, Volume 54, Issue 11, pp. 4684 - 4693
Journal Article
Drugs, ISSN 0012-6667, 2015, Volume 75, Issue 3, pp. 253 - 270
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 01/2012, Volume 10, Issue 4, pp. 459 - 473
Journal Article
Journal Article
mBio, ISSN 2161-2129, 03/2016, Volume 7, Issue 2, p. e00169
Clay minerals are naturally occurring layered phyllosilicates which consist of fine particles and possess antimicrobial activity. In a recent article,... 
MICROBIOLOGY | LACTAMASE INHIBITOR COMBINATION | HOSPITALS CANWARD | EPIDEMIOLOGY | SUSCEPTIBILITY | PATHOGENS | Microbial Sensitivity Tests | Anti-Bacterial Agents | Humans | Aluminum Silicates | British Columbia | Anti-Infective Agents | Staphylococcus aureus
Journal Article
Canadian Journal of Infectious Diseases and Medical Microbiology, ISSN 1712-9532, 2018, Volume 2018, pp. 1404813 - 9
Journal Article
Canadian Journal of Infectious Diseases and Medical Microbiology, ISSN 1712-9532, 2018, Volume 2018, pp. 8912039 - 13
Journal Article